Joey L Methot Selected Research

hematopoietic progenitor kinase 1

4/2021	Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.
1/2020	Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joey L Methot Research Topics

Disease

5	Neoplasms (Cancer) 04/2021 - 12/2008
1	Inflammation (Inflammations) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Allergic Rhinitis 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Vascular System Injuries 01/2019
1	Melanoma (Melanoma, Malignant) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 09/2015

Drug/Important Bio-Agent (IBA)

2	hematopoietic progenitor kinase 1IBA 04/2021 - 01/2020
2	Histones (Histone)IBA 12/2013 - 12/2008
1	CytokinesIBA 04/2021
1	duvelisibIBA 01/2021
1	OvalbuminIBA 01/2021
1	idelalisibIBA 01/2021
1	benzimidazoloneIBA 01/2019
1	piperidineIBA 01/2019
1	purineIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	compound 21IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2015
1	AmidesIBA 09/2015
1	Vorinostat FDA Link 12/2013

Therapy/Procedure

1	Immunotherapy 01/2020